Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Kilitch Healthcare India Limited
483
•Kilitch Healthcare India Limited•October 20, 2023

Kilitch Healthcare India Limited – FDA 483, Oct 20, 2023

Record Details

On October 12-20, 2023, the FDA inspected Kilitch Healthcare India Limited, a sterile drug manufacturing facility in Navi Mumbai, Maharashtra, India. The inspection, documented in a Form 483 issued to Managing Director Paresh Mehta, revealed significant deficiencies in aseptic processing, laboratory controls, and validation of sterile drug products.

Observation 1 highlights inadequate cleaning and disinfection in aseptic areas. The firm lacks assurance of effective sporicidal use, with no validation data for the [(b)(4)] process's efficacy against spores or its penetration. Disinfectant efficacy studies omitted critical surfaces like [(b)(4)], [(b)(4)], [(b)(4)], and [(b)(4)]. Additionally, mops used in the filling room were unsterilized and moved between Grade C and Grade B areas.

Observation 2 details unreliable laboratory controls. Environmental and personnel monitoring data are compromised due to issues with in-house prepared media, including insufficient media volume, desiccation, cracking, and lack of neutralizers, leading to disinfectant interference. The firm also lacks appropriate specifications for impurities or degradation products for US market [(b)(4)] products. During sterility testing, components were not fully submerged in media.

Observation 3 indicates inadequate validation of the aseptic process. Smoke studies for Lines [(b)(4)] and [(b)(4)] showed turbulent airflow and failed to include critical set-up activities or interventions. Aseptic Process Simulation (Media

Company
Kilitch Healthcare India Limited
Inspection date
October 20, 2023
Product type
drugs
Office
Office of Biological Products Operations - Division I
People
  • Justin A. Boyd (Research Specialist II)
  • Anastasia M. Shields (Consumer Safety Officer )
View Company Profile

ID · 47a7622c-31c9-4332-be63-94ab1dc5850b

Violation Codes2
21 CFR 21121 CFR 210

Full citation text and observation details available on the Dashboard.

Other documents for Kilitch Healthcare India Limited
  • WARNING_LETTER - 2023-10-20October 20, 2023

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kilitch Healthcare India Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.